Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00980889
What this trial is testing

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Who this might be right for
Biliary Tract NeoplasmsPancreatic NeoplasmsStent Occlusion
Stockholm South General Hospital 400
Early research (Phase 1)Study completedNCT00034281
What this trial is testing

Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

Who this might be right for
Breast NeoplasmPancreatic NeoplasmLung Neoplasm+2 more
Takeda 16
Not applicableWithdrawnNCT07558330
What this trial is testing

Evaluation of the Clinical Impact of the Numerique Medical Device MAELA® Ont the Care Pathway in Digestive Oncology Surgery

Who this might be right for
Digestive Cancers
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)UnknownNCT05279677
What this trial is testing

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Who this might be right for
Colorectal Neoplasms Malignant
Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerSolid CancersGastric Cancer
Weijia Fang, MD 58
Testing effectiveness (Phase 2)Study completedNCT00861107
What this trial is testing

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Who this might be right for
Metastatic Cancer
Mirror Biologics, Inc. 50
Early research (Phase 1)Study completedNCT02571036
What this trial is testing

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Who this might be right for
Gastrointestinal Stromal TumorsAdvanced Systemic MastocytosisAdvanced Cancers
Deciphera Pharmaceuticals, LLC 282
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Not applicableStudy completedNCT02797197
What this trial is testing

Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy

Who this might be right for
Handgrip Strength TestSarcopeniaDigestive Cancer+2 more
CHU de Reims 201
Testing effectiveness (Phase 2)Study completedNCT00289445
What this trial is testing

Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)

Who this might be right for
Gastrointestinal NeoplasmsNeoplasm Metastasis
University Hospital Tuebingen
Not applicableStudy completedNCT06588881
What this trial is testing

Endoscopic Nebulizing Device for Surgical Haemostatic-sealant Glubran® 2 Usability Trial in EMR and ESD

Who this might be right for
Gastrointestinal Cancer
GEM SRL 15
Not applicableStudy completedNCT06551675
What this trial is testing

Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery

Who this might be right for
Nutritional DeficiencyGastrointestinal CancerFrailty Syndrome
Xiaosun Liu, MD 120
Not applicableLooking for participantsNCT06413212
What this trial is testing

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Who this might be right for
Lung CancerBreast CancerGastric Cancer+1 more
Liu Huang 55
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Not applicableEnded earlyNCT03108885
What this trial is testing

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

Who this might be right for
Esophageal NeoplasmEsophageal Neoplasms Malignancy UnspecifiedEsophageal Neoplasms Malignant+5 more
Mayo Clinic 11
Not applicableLooking for participantsNCT07483658
What this trial is testing

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Who this might be right for
Reccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate Cancer+3 more
CHU de Quebec-Universite Laval 434
Testing effectiveness (Phase 2)Ended earlyNCT03745326
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Who this might be right for
Gastrointestinal CancerPancreatic CancerGastric Cancer+2 more
National Cancer Institute (NCI) 5
Next Page